⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11894064 | 0.74 | — | — | |
| SCHEMBL25378286 | 0.74 | — | — | |
| SCHEMBL22016090 | 0.74 | — | — | |
| SCHEMBL12096477 | 0.74 | FGFR1 (0.39) | — | |
| SCHEMBL1179743 | 0.74 | PDE3A (0.36) | — | |
| SCHEMBL5985575 | 0.73 | — | — | |
| SCHEMBL4492972 | 0.73 | — | — | |
| SCHEMBL8944773 | 0.73 | — | — | |
| SCHEMBL7876669 | 0.73 | — | — | |
| SCHEMBL19692381 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 173 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025038971-A1 | OLIGONUCLEOTIDES CONTAINING A LIGAND AT A NUCLEOBASE, 2' POSITION, OR 3' POSITION | ADARX PHARMACEUTICALS, INC. (US) | 2025-02-20 | — | — | WO | claimed |
| CN-118086264-A | Cytidine deaminase immobilization based on T4 phage-bound magnetic bead composite material | 江苏海洋大学 | 2024-05-28 | — | — | CN | claimed |
| CN-117881403-A | Thionucleosides as antiviral agents | 爱莫里大学 | 2024-04-12 | — | — | CN | claimed |
| CN-117858711-A | Nucleoside and nucleotide analogs as antiviral agents | 爱莫里大学 | 2024-04-09 | — | — | CN | claimed |
| CN-117512078-A | Single primer to double primer amplicon conversion | 西格马-奥尔德里奇有限责任公司 | 2024-02-06 | — | — | CN | claimed |
| US-20230357168-A1 | CARBOBICYCLIC NUCLEOSIDES FOR TREATMENT OF VIRAL INFECTION | UNIV HONG KONG CHINESE (CN) | 2023-11-09 | — | — | US | claimed |
| CN-109804083-B | Single primer to double primer amplicon conversion | 西格马-奥尔德里奇有限责任公司 | 2023-11-03 | — | — | CN | claimed |
| WO-2023198181-A1 | CARBOBICYCLIC NUCLEOSIDES FOR TREATMENT OF VIRAL INFECTION | THE CHINESE UNIVERSITY OF HONG KONG (CN) | 2023-10-19 | — | — | WO | claimed |
| US-20220315972-A1 | SINGLE PRIMER TO DUAL PRIMER AMPLICON SWITCHING | SIGMA ALDRICH CO LLC (US) | 2022-10-06 | — | — | US | claimed |
| US-11390913-B2 | Single primer to dual primer amplicon switching | SIGMA-ALDRICH CO. LLC (US) | 2022-07-19 | — | — | US | claimed |
| US-20210332078-A1 | COMPOSITIONS AND METHODS FOR NUCLEIC ACID AMPLIFICATION | Twist Bioscience Corporation | 2021-10-28 | — | — | US | claimed |
| EP-3516075-A1 | SINGLE PRIMER TO DUAL PRIMER AMPLICON SWITCHING | Sigma-Aldrich Co., LLC (US) | 2019-07-31 | — | — | EP | claimed |
| US-20190211386-A1 | SINGLE PRIMER TO DUAL PRIMER AMPLICON SWITCHING | SIGMA-ALDRICH CO. LLC | 2019-07-11 | — | — | US | claimed |
| CN-109804083-A | Single primer to double primer amplicon conversion | 西格马-奥尔德里奇有限责任公司 | 2019-05-24 | — | — | CN | claimed |
| WO-2018057846-A1 | SINGLE PRIMER TO DUAL PRIMER AMPLICON SWITCHING | SIGMA-ALDRICH CO, LLC (US) | 2018-03-29 | — | — | WO | claimed |
| US-20160333340-A1 | COMPOSITIONS AND METHODS FOR NUCLEIC ACID AMPLIFICATION | Twist Bioscience Corporation | 2016-11-17 | — | — | US | claimed |
| WO-2016183100-A1 | COMPOSITIONS AND METHODS FOR NUCLEIC ACID AMPLIFICATION | Twist Bioscience Corporation (US) | 2016-11-17 | — | — | WO | claimed |
| EP-2271653-A2 | NOVEL METHOD FOR PREPARING OLIGONUCLEOTIDES COMPRISING A 5' -PHOSPHATE MONOESTER OR 5' -THIOPHOSPHATE MONOESTER END | Université Joseph Fourier (FR) | 2011-01-12 | — | — | EP | claimed |
| WO-2009138614-A2 | NOVEL METHOD FOR PREPARING OLIGONUCLEOTIDES COMPRISING A 5’-PHOSPHATE MONOESTER OR 5’-THIOPHOSPHATE MONOESTER END | UNIVERSITE JOSEPH FOURIER (FR) | 2009-11-19 | — | — | WO | claimed |
| WO-2008033432-A2 | IMMUNE MODULATION BY CHEMICALLY MODIFIED RIBONUCLEOSIDES AND OLIGORIBONUCLEOTIDES | COLEY PHARMACEUTICAL GROUP, INC. (US) | 2008-03-20 | — | — | WO | claimed |